Health Canada grants nod for Ceapro's anti-inflammatory drug trial
Health Canada has granted clearance to Ceapro to initiate the Phase I/IIa trial of its pharmaceutical-grade tablet of avenanthramide.
Source: clinicaltrialsarena.com
Stay updated with breaking news from Corealis Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Health Canada has granted clearance to Ceapro to initiate the Phase I/IIa trial of its pharmaceutical-grade tablet of avenanthramide.
Laval bio-science companies involved in COVID-19 research | The Laval News | Serving Laval Since 1993